V. Leblond Et Al. , "Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).," 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , vol.120, Georgia, United States Of America, 2012
Leblond, V. Et Al. 2012. Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Georgia, United States Of America).
Leblond, V., Laribi, K., İLHAN, O., Aktan, M., ÜNAL, A., Rassam, S. M. B., ... Schuh, A.(2012). Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe). . 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America
Leblond, Veronique Et Al. "Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).," 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 2012
Leblond, Veronique Et Al. "Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).." 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Georgia, United States Of America, 2012
Leblond, V. Et Al. (2012) . "Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).." 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Georgia, United States Of America.
@conferencepaper{conferencepaper, author={Veronique Leblond Et Al. }, title={Rituximab in Combination with Bendamustine or Chlorambucil for Treating Patients with Chronic Lymphocytic Leukemia: Interim Results of a Phase IIIb Study (MaBLe).}, congress name={54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Georgia}, country={United States Of America}, year={2012}}